CLINICAL THYROIDOLOGY
APRIL 2011
VOLUME 23 ISSUE 4
Editor: Jerome M. Hershman, MD
TABLE OF CONTENTS
Clinical Thyroidology April 2011 Entire Issue (PDF File, 1.69 MB, 23 pages)
(Note: the links below open the individual articles in this issue for saving and printing)
- PERSPECTIVE — PROPYLTHIOURACIL IS AN OLD BUT STILL USEFUL DRUG
- MODIFIED-RELEASE RECOMBINANT HUMAN TSH AUGMENTS THE EFFECT OF 131I THERAPY IN BENIGN MULTINODULAR GOITER
- IS OBESITY DIRECTLY INVOLVED IN CAUSING THYROID CANCER?
- SUPPLEMENTATION OF METHIMAZOLE TREATMENT WITH MODERATE DOSES OF IODIDE (38 MG/DAY) QUICKLY IMPROVES HYPERTHYROIDISM
- LEVOTHYROXINE INGESTION IN THE EVENING RESULTS IN BETTER ABSORPTION THAN INGESTION BEFORE BREAKFAST
- ULTRASONOGRAPHY MAY DETECT MALIGNANT NODULES IN PATIENTS WITH HASHIMOTO’S DISEASE
- PROGRESSION FROM EUTHYROID AUTOIMMUNE DISEASE TO CLINICAL DISEASE: HOW OFTEN, HOW SOON?
- CHILDREN WITH PRADER–WILLI SYNDROME FREQUENTLY HAVE CENTRAL HYPOTHYROIDISM
- REVIEW ARTICLES AND GUIDELINES
CLINICAL THYROIDOLOGY, this highly valued abstract and commentary publication provides a broad-ranging look at the clinical thyroid literature. Experts in the field summarize the most cutting-edge, relevant articles that clinicians should know about and provide insight into the relevance and impact of each article on patient care.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.